This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Malignant hyperpyrexia

Authoring team

Malignant hyperpyrexia is a rare condition which can occur after exposure to most general anaesthetic or muscle relaxants, resulting in:

  • widespread skeletal muscle rigidity
  • hyperpyrexia
  • acidosis

On exposure to the initiating agent, there is an acute rise in intracellular calcium which causes rigidity, muscle necrosis and hyperpyrexia with a rate of increase of greater than 2 degrees centrigrade every hour.

Plasma levels of creatine kinase may be extremely high during the acute phase.

Diagnosis is made by in vitro exposure of muscle to halothane or suxamethonium.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.